Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

2,999 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

The Ambient Light Multiple Myeloma Study

NCT05737732

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Icahn Schoool of Medicine at Mount Sinai New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View Trial Details
Recruiting

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

NCT05947136

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Complication, +13 more
Locations
  • CH Annecy Genevois Épagny, France
  • CHU La Tronche Grenoble, France
  • Centre Léon Bérard Lyon, France
  • CENTRE HOSPITALIER UNIVERSITAIRE de MONTPELLIER Montpellier, France
View Trial Details
Recruiting

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

NCT07095452

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Hospital Scottsdale /ID# 278349 Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center /ID# 278238 Los Angeles, California, United States
  • Colorado Blood Cancer Institute /ID# 279080 Denver, Colorado, United States
  • Winship Cancer Institute of Emory University /ID# 277667 Atlanta, Georgia, United States
View all 49 locations
View Trial Details
Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

NCT06215118

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center Coral Gables, Florida, United States
  • University of Miami Hospital and Clinics Deerfield Beach Deerfield Beach, Florida, United States
  • Sylvester Comprehensive Cancer Center- Doral Doral, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 43 locations
View Trial Details
Recruiting

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

NCT05561387

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 397 locations
View Trial Details

Related conditions